Dong-Soon Im
College of Pharmacy (BK21 Project) and Longevity Institute of Life Science and Technology
Pusan National University
Busan 609-735
Korea
Name/email consistency: high
- First-in-class antifibrotic therapy targeting type 1 lysophosphatidic acid receptor. Im, D.S. Arch. Pharm. Res. (2012)
- Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors. Im, D.S. Acta Pharmacol. Sin. (2010)
- Differential change of Ins-P3-Ca2+ signaling during culture of rat hepatocytes. Im, D.S., Nagano, K., Katada, T., Okajima, F., Ui, M. Cell. Signal. (2005)
- Two ligands for a GPCR, proton vs lysolipid. Im, D.S. Acta Pharmacol. Sin. (2005)
- Discovery of new G protein-coupled receptors for lipid mediators. Im, D.S. J. Lipid Res. (2004)
- Enhancement of sphingosine 1-phosphate-induced phospholipase C activation during G(0)-G(1) transition in rat hepatocytes. Im, D.S., Tomura, H., Tobo, M., Tobe, M., Sato, K., Okajima, F. J. Pharmacol. Sci. (2004)
- Linking Chinese medicine and G-protein-coupled receptors. Im, D.S. Trends Pharmacol. Sci. (2003)
- Orphan G protein-coupled receptors and beyond. Im, D.S. Jpn. J. Pharmacol. (2002)